4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-046846
Chief Executive Officer sold 50,000 shares at $41.35 ($2,067,500)
- Chief Executive Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2020-08-13 | Option exercise | +50,000 | $9.90 | $495,000 | 2,655,237 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2020-08-13 | Sale | −50,000 | $41.35 | $2,067,500 | 2,605,237 | D |
| Derivatives | |||||||
| Anzalone Christopher Richard Chief Executive Officer | 2020-08-13 | Option exercise · Stock Option (right to buy) | −50,000 | 895,543 | D | ||
| Open-market sales · 50,000 sh · avg $41.35 · $2,067,500 | |||||||
Loading xslF345X03/doc4.xml…